ICU · GI & nutrition / surgical
Acute cholangitis and biliary sepsis
Also known as Acute cholangitis · Ascending cholangitis · Biliary sepsis · Biliary obstruction · Charcot triad · Reynolds pentad · Tokyo Guidelines (TG18) · Choledocholithiasis · ERCP biliary drainage · Suppurative cholangitis
Acute cholangitis is bacterial infection of an obstructed biliary tree — a life-threatening emergency. Biliary obstruction raises intraductal pressure, bacteria proliferate in stagnant bile, and infected bile refluxes into the systemic circulation producing bacteraemia and septic shock. Charcot triad (fever + jaundice + RUQ pain) has limited sensitivity and is now only one limb of the Tokyo Guidelines 2018 diagnostic criteria. Reynolds pentad (Charcot + hypotension + altered mental status) indicates severe (Grade III) cholangitis with septic shock. Management: immediate empiric antibiotics — a third-generation cephalosporin first-line for community-acquired disease (E. coli and Klebsiella the main pathogens), broadened for severe or healthcare-associated infection — plus biliary drainage by ERCP timed by severity: urgent drainage for Grade III after initial resuscitation, early drainage for Grade II. Antibiotics alone are insufficient — drainage is the definitive source control.
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- Biliary DRAINAGE (ERCP) is the definitive treatment — antibiotics alone do not control moderate-severe cholangitis; mortality rises steeply when drainage is delayed
- Reynolds pentad = severe (Grade III) cholangitis with septic shock — urgent biliary drainage after initial resuscitation + ICU admission
- Do NOT delay drainage for exhaustive imaging if diagnosis is clear — resuscitate in parallel
- Distinguish cholangitis (duct obstruction, jaundice, needs ERCP) from cholecystitis (gallbladder inflammation, Murphy sign, needs cholecystectomy)
- Empiric antibiotics must cover Enterobacteriaceae (E. coli number one) — a third-generation cephalosporin is first-line for community-acquired disease; broaden for severe or healthcare-associated infection (a biliary stent selects multidrug-resistant flora)
- Post-ERCP pancreatitis is the commonest procedure complication — give prophylactic rectal NSAID to eligible patients and watch for abdominal pain after ERCP
- Atypical presentation in elderly/immunocompromised — may not mount fever; index of suspicion must be high
- Correct coagulopathy before ERCP where possible but do NOT let coagulopathy delay drainage in severe disease
Meet the patient
A 74-year-old man is brought in confused, rigoring, and yellow. Temperature 39.4, heart rate 128, blood pressure 82 over 48, and he is tender in the right upper quadrant. Bedside ultrasound shows a dilated common bile duct with a stone. The registrar orders another scan; the consultant is already calling the endoscopist.[1]
The decision that decides this man's survival is not which antibiotic — it is how fast the obstructed duct is decompressed. Antibiotics cannot sterilise bile under pressure; drainage is the source control. Hold that and every Tokyo Guideline threshold slots into place.[4]
References13ShowHide
- [1]Kiriyama S, Kozaka K, Takada T, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholangitis (with videos) J Hepatobiliary Pancreat Sci, 2018.PMID 29032610
- [2]Sokal A, Sauvanet A, Fantin B, de Lastours V Acute cholangitis: Diagnosis and management J Visc Surg, 2019.PMID 31248783
- [3]Venkat Rao G, Tandan M, Bruno MJ, Reddy ND Urgent versus early ERCP in mild-to-moderate acute cholangitis: a randomised controlled trial Gut, 2026.PMID 42161575
- [4]Takada T. Tokyo Guidelines 2018: updated Tokyo Guidelines for the management of acute cholangitis/acute cholecystitis J Hepatobiliary Pancreat Sci, 2018.PMID 29334699
- [5]Gomi H, Solomkin JS, Takada T, et al. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis J Hepatobiliary Pancreat Sci, 2018.PMID 29090866
- [6]Miura F, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: initial management of acute biliary infection and flowchart for acute cholangitis J Hepatobiliary Pancreat Sci, 2018.PMID 28941329
- [7]Mayumi T, Okamoto K, Takada T, et al. Tokyo Guidelines 2018: management bundles for acute cholangitis and cholecystitis J Hepatobiliary Pancreat Sci, 2018.PMID 29090868
- [8]Huang YC, Wu CH, Lee MH, et al. Timing of endoscopic retrograde cholangiopancreatography in the treatment of acute cholangitis of different severity World J Gastroenterol, 2022.PMID 36304084
- [9]Gravito-Soares E, Gravito-Soares M, Gomes D, et al. Clinical applicability of Tokyo guidelines 2018/2013 in diagnosis and severity evaluation of acute cholangitis and determination of a new severity model Scand J Gastroenterol, 2018.PMID 29374984
- [10]Schmitz D, Gornals JB, Vila JJ, et al. Percutaneous transhepatic biliary drainage versus endoscopic ultrasound-guided biliary drainage with primary metal stenting for unresectable malignant distal biliary obstruction Endoscopy, 2026.PMID 42128368
- [11]Nabi Z, Reddy DN Post-ERCP Pancreatitis: New Insights, Evolving Therapies, and the Road Ahead Visc Med, 2026.PMID 42199695
- [12]Qi ZP, Wan R, Wan XJ, et al. Low-dose rectal indomethacin to prevent post-ERCP pancreatitis: results of a large Chinese multicenter randomized noninferiority trial Endoscopy, 2026.PMID 42140208
- [13]Cao L, et al. Comparative analysis of cefoperazone-sulbactam and piperacillin-tazobactam in empirical treatment of acute biliary tract infections: a multicenter, retrospective, real-world study Sci Rep, 2026.PMID 42477084